Simplify MAb Production by Eliminating Contaminating IgG and Reducing Cost
|| Print ||
|Wednesday, 27 April 2011 10:00 (UTC + 2)|
InVitria and Lampire to Host Webinar on Monoclonal Antibody Production
Fort Collins, CO, USA, April 27, 2011 / B3C newswire / – InVitria and Lampire Biological are hosting a webinar to share a strategy to eliminate contaminating IgG’s from serum while reducing monoclonal antibody (MAb) production costs. The webinar will be broadcast live at 11:30am EST on May 10, 2011 and will be archived on InVitria’s website for future viewing.
During this webinar, the challenges facing non-therapeutic MAb production will be discussed. Annette Flood, Monoclonal Department Manager, Lampire Biological Laboratory will present a case study to show Lampire’s success in reducing costs and improving performance in serum-free hybridoma cell culture conditions and Mab production.
“The development of technologies to improve the consistency and purification of monoclonal antibody production is key to reducing manufacturing costs,” said Brittany Medbery, InVitria. “In this webinar we will share the successful implementation of this technology.”
To sign up for the webinar “Serum-Free Cell Culture Can Cost Less: Simplify MAb Production by Eliminating Contaminating IgG and Reducing Cost”, register here.
About Lampire Biological Laboratory - www.lampire.com
For additional information, contact Lampire at 215-795-2838 or visit their website www.Lampire.com.